Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. Nov 7, 2022; 28(41): 5893-5909
Published online Nov 7, 2022. doi: 10.3748/wjg.v28.i41.5893
Table 3 Diagnostic criteria to establish diagnosis and assess disease severity (modified from Schauer et al[20])
Macroscopic-endoscopic criteria
Specific signs
DDenudation/sloughing of the mucosa
D1Iatrogenic denudation (caused by biopsies)
D2Spontaneous localized denudation < 1 cm2
D3Spontaneous spacious denudation > 1 cm2
Possible signs
SStenosis/stricture
S1Passable with standard endoscope
S2Not passable with standard endoscope
HHyperkeratosis (whitish, rough mucosa)
TTrachealization
NNone of the criteria fulfilled
Microscopic criteria- histopathology and direct immunofluorescence
HPSloughing of the epithelia (subepithelial, intraepithelial)
Lymphocytic infiltrate, mainly T-lymphocytes subepithelial, intraepithelial, junctional (region of the basal membrane)
Intraepithelial apoptosis of keratinocytes (Civatte bodies)
Dyskeratosis
HP0Negative
HP1Weakly positive
HP2Positive
HP3Strong positive
FFibrinogen deposition along the basal membrane
F0No visible reaction
F1Weak positive, discrete depositions visible
F2Marked fibrinogen depositions along the basal membrane
Severity grading
Severe ELP≥ D2 and HP ≥ 1 and/or F ≥ 1
Mild ELPD1 and HP ≥ 1 and/or F ≥ 1; S, H, T, N and HP ≥ 1 and F ≥ 1
No ELPCriteria not fulfilled in a patient with LP on other localization